Absorption, metabolism, and excretion of (2)-epicatechin in humans: An evaluation of recent findings

American Journal of Clinical Nutrition

Volumn 98, Issue 4, 2013, Pages 861-862

  Crozier, Alan ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPICATECHIN;

BILIARY EXCRETION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DIETARY INTAKE; EDITORIAL; ENTEROHEPATIC CIRCULATION; INCUBATION TIME; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE PERFUSION; JEJUNUM; MAXIMUM PLASMA CONCENTRATION; METABOLISM; MORBIDITY; SMALL INTESTINE; STEREOISOMERISM; URINARY EXCRETION; VATER PAPILLA;

CATECHIN; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE;

EID: 84884883813     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.072009     Document Type: Editorial

References (12)

1. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Version 3. 2013. Available from: http://www.phenolexplorer. eu (cited 16 August 2013).
2. Del Rio D, Rodrigues-Mateus A, Spencer JPE, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013;18:1818-92.
3. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmidt HH, Kelm M. (2)-Epicatechin mediates beneficial effects of flavonol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006;103:1024-9. (Pubitemid 43212215)
4. Crozier A, Clifford MN, Del Rio D. Bioavailability of dietary monomeric and polymeric flavan-3-ols. In: Spencer JPE, Crozier A, eds. Bioavailability and function of flavonoids: oxidative stress and disease. Vol 30. Boca Raton, FL: CRC Press, 2012:45-78.
5. Ottaviani JI, Momma TY, Kuhnle G, Keen CL, Schroeter H. Structurally related (2)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic Biol Med 2012;52:1403-12.
6. Actis-Goretta L, Lévèques A, Romanov-Michailidis F, Viton F, Barron D, Duenas-Paton M, Gonzales-Manzano S, Santos-Buelga C, Williamson G, Dionisi F. Elucidation of (2)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic Biol Med 2012;53:787-95.
7. Actis-Goretta L, Lévèques A, Rein M, Teml A, Schäfer C, Hofmann U, Li H, Schwab M, Eichelbaum M, Williamson G. Intestinal absorption, metabolism, and excretion of (2)-epicatechin in healthy humans assessed by using an intestinal perfusion technique. Am J Clin Nutr 2013;98:924-33.
8. Dahan A, Lennernäs H, Amidon GL. Fraction dose absorbed, in humans, and high jejunum permeability relationship. Mol Pharm 2012;9: 1847-51.
9. Stalmach A, Mullen W, Steiling H, Williamson G, Lean MEJ, Crozier A. Absorption, metabolism and excretion of flavan-3-ols in humans with an ileostomy. Mol Nutr Food Res 2010;54:323-34.
10. Stalmach A, Edwards CA, Wightman JD, Crozier A. Gastrointestinal stability and bioavailability of (poly)phenolic compounds following ingestion of Concord grape juice by humans. Mol Nutr Food Res 2012; 56:497-509.
11. Urpi-Sarda M, Monagas M, Khan N, Llorach R, Lamuela-Raventos RM, Jáurequi O, Etsruch R, Izquierdo-Pulido M, Andrés-Lacueva C. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2009;1216:7258-67.
12. Roowi S, Stalmach A, Mullen W, Lean MEJ, Edwards CA, Crozier A. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J Agric Food Chem 2010;58:1296-304.